Skip to main content

FDA recall, , Moderate risk

ArjoHuntleigh Polska Sp. Z.O.O. Carevo Height-Adjustable Shower Trolley

The Carevo height-adjustable shower trolley can open unintentionally, leading to patient falls and serious injury.

What happened

Arjohuntleigh Polska Sp. z.o.o. of Komorniki, Poland, is voluntarily recalling the Carevo height-adjustable shower trolley, Model Number BAC1111-01, because the side support may open unintentionally when the handles are not fully locked and additional force is applied during patient handling. The FDA added the recall to its Enforcement Report on October 29, 2026.

The recall began on September 25, 2026, and involves 8780 units distributed nationwide in the US. The agency classified the recall on October 29, 2026, and included it in the weekly enforcement report on November 4, 2026.

What to do

The FDA notice gives no instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number matches.

  1. Carevo Height-adjustable shower trolley

    Model number
    • BAC1111-01

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

US Nationwide distribution.

Recalled by
ARJOHUNTLEIGH POLSKA Sp. z.o.o.Komorniki, Poland
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
99900
Recall number
Z-0315-2027
Quantity recalled
8780 units
Recall type
Voluntary: Firm initiated

All recalls from ARJOHUNTLEIGH POLSKA Sp. z.o.o.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. ARJOHUNTLEIGH POLSKA Sp. z.o.o. began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

  4. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 31, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)